Product logins

Find logins to all Clarivate products below.


Dental Implants | Market Insights | Europe | 2021

The European dental implant market will be hindered by the COVID-19 pandemic in the short term. However, once the impact subsides, the market will see modest growth throughout the forecast period driven by growing awareness of the benefits of dental implant surgery and more trained physicians. Although stringent regulations and economic constraints in some countries will continue to limit dental implant procedure volumes to some degree, rising aesthetic consciousness and the increasing availability of low-cost products will support dental implant adoption, leading to sustained market growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for dental implants in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Dental Implants – Market Insights – Europe
The European dental implant market is projected to experience modest expansion through 2035. Growth is driven by an aging population with ongoing long-term restorative needs, a persistent burden of…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…